Whole genome insight, within reach of the mass market.
Consumer genomics at a mass market price, powered by the same nucleic acid expertise that runs through Syngenis.
Whole genome insight, made accessible.
Life Care brings the nucleic acid expertise behind our therapeutics pipeline directly to consumers, with whole genome sequencing that reads across all three billion base pairs for a complete genetic picture. It extends the same science that powers our medicine into everyday health and wellbeing.
The expertise behind our therapeutics, brought directly to you.
Five areas of insight.
Health and wellness
Genomic insight to support everyday health and wellbeing.
Ancestry and heritage
Understand your origins across a complete genetic picture.
Pharmacogenomics
How your body may respond to certain medicines.
Disease risk
Insight into inherited and genetic disease risk.
Reproductive health
Genetic insight to support reproductive planning.
How it works.
A free tier opens access, with deeper insights available across each area. Life Care is designed for broad reach through Australia's major retail pharmacy networks, so genomic insight is available close to home. Over time, the anonymised, consented data also strengthens the wider Syngenis platform.
Your data, handled with care.
Life Care is built on strong privacy and consent. You stay in control of how your genomic data is stored, used and protected, and you can withdraw that consent at any time.
Life Care health and genomics information is general in nature. Data, privacy and consent details are being finalised and confirmed with our advisers ahead of launch, and nothing here is intended as medical advice.
Ready to work with an integrated life sciences company?
Talk to our team about your program, from candidate design to trial ready material.
One engine, working across the whole business.
Syngenis One (AI Discovery)
Design RNA and DNA candidates from target to synthesis ready oligo in one workflow.
Manufacturing
Australia's only commercial RNA facility. Custom oligonucleotides, ordered through Syngenis One.
Research and Diagnostics
AI led therapeutic programs and an aptamer based diagnostics pipeline.
Clinical
A specialist nucleic acid CRO with in silico trial modelling.
Life Care
Consumer genomics at a mass market price.
Fund
Infrastructure that channels research investment into the pipeline.